Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Rev. méd. Chile ; 123(2): 165-75, feb. 1995. tab, ilus
Article in Spanish | LILACS | ID: lil-151169

ABSTRACT

Tyrosine protein kinase (TPK) activity is associated to malignant cellular transformation. This work compares TPK activity in 27 surgical biopsy samples of mammary carcinoma, 10 samples of normal mammary tissue. TPK activity was determined in tissue homogenates using (Val5) angiotensin II as exogenous substrate. In samples of mammary carcinoma, TPK activity was 33.86 ñ 31.98 pmol P32/mg protein/30 min. This value was significantly higher that those observed in fibrocystic disease (3.92 ñ 2.35), fibroadenomas (13.86 ñ 10.9) and normal tissue (3.56 ñ 3.02)


Subject(s)
Humans , Female , Adult , Middle Aged , Protein-Tyrosine Kinases/biosynthesis , Breast Neoplasms/enzymology , Breast/enzymology , Breast Diseases/enzymology , Carcinoma/enzymology , Case-Control Studies , Fibroadenoma/enzymology
2.
Indian J Pathol Microbiol ; 1991 Apr; 34(2): 126-30
Article in English | IMSEAR | ID: sea-75146

ABSTRACT

Serum cholinesterase (ChE) and Lactate dehydrogenase (LDH) activities were estimated in 40 cases of carcinoma breast, 25 cases of benign tumours and compared with healthy controls (30 cases). Significant difference in enzyme activities were obtained between benign and malignant neoplasms of the breast when compared with each other as well as when compared with healthy controls. Also, there were significant enzyme changes between non-metastatic cases and those with metastasis and when Stage I and Stage II cancers were compared with those in Stage III and Stage IV. No difference in enzyme levels were recorded between pre and post-operative cases and in different types of breast cancers. While ChE was depressed in 80 per cent cases of malignancy breast, serum LDH was raised in 73.3 per cent cases.


Subject(s)
Breast Diseases/enzymology , Breast Neoplasms/diagnosis , Cholinesterases/blood , Female , Humans , L-Lactate Dehydrogenase/blood , Male , Neoplasm Staging , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL